Clint Cary - Concepedia

Author

Clint Cary

Indiana University – Purdue University Indianapolis

Also Known As

C Cary, C. Cary, Cary, Clint, Clint Cary, Kelly Cary

189

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Indiana University Health Case Western Reserve University Washington University in St. Louis

About

Clint Cary is an author at Indiana University – Purdue University Indianapolis specializing in medicine, surgery, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	466
2	Health Sciences	2	2	78
3	Obstetrics	2	2	41
4	Public Health	1	1	21
5	Cell Biology	1	1	61

Clint Cary

Publications

Citations

H-Index

Page 1

	Year	Citations
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy Siamak Daneshmand, Clint Cary, Timothy A. Masterson, Journal of Clinical Oncology	2023	92
Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration Patrizia Giannatempo, Gregory R. Pond, Guru Sonpavde, The Journal of Urology	2015	88
Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors Costantine Albany, Nabil Adra, Anna C. Snavely, Annals of Oncology	2017	76
Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer Adam Calaway, Lawrence H. Einhorn, Timothy A. Masterson, European Urology LaparoscopyUrologySurgical OncologyTesticular CancerMedicine	2019	63
Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors Lucia Nappi, Marisa Thi, Nabil Adra, European Urology Tumor BiologyMedicineCirculating Mir375PathologyIdentify Teratoma	2020	61
Contemporary trends in postchemotherapy retroperitoneal lymph node dissection: Additional procedures and perioperative complications Clint Cary, Timothy A. Masterson, Richard Bihrle, Urologic Oncology Seminars and Original Investigations LaparoscopySurgical OncologyMinimally Invasive ProcedurePerioperative ComplicationsVisceral Surgery	2015	58
Modified retroperitoneal lymph node dissection for post‐chemotherapy residual tumour: a long‐term update Jane S. Cho, Hristos Z. Kaimakliotis, Clint Cary, British Journal of Urology	2017	51
Phase Ib/II neoadjuvant (N-) pembrolizumab (P) and chemotherapy for locally advanced urothelial cancer (laUC): Final results from the cisplatin (C)- eligible cohort of HCRN GU14-188. Christopher Hoimes, Nabil Adra, Mark T. Fleming, Journal of Clinical Oncology Gu14-188 TrialRadical CystectomySurgical OncologyPharmacotherapySurgery	2020	49
A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC) Christopher Hoimes, Costantine Albany, Jean Hoffman‐Censits, Annals of Oncology UrologyGenitourinary CancerMedicineImmune Checkpoint InhibitorAdvanced Urothelial Cancer	2018	35
SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma. Siamak Daneshmand, Clint Cary, Timothy A. Masterson, Journal of Clinical Oncology Surgical OncologyCancer ManagementSurgeryGynecology OncologyTesticular Tumours	2021	32

Page 1